Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07524751 · ClinicalTrials.gov registry record · NA

Culturally Adapted Pain Management for Indigenous Peoples

A NA study, sponsored by University of California, San Diego.

Recruiting
Registry status
NA
Development phase
30
Enrollment target

NCT07524751: Recruiting NA study, sponsored by University of California, San Diego.

NCT07524751 is a NA study that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07524751, a NA study, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The proposed study involves a randomized feasibility pilot trial of a culturally adapted psychological intervention for chronic pain for American Indian/Alaska Native (AI/AN) individuals receiving care for pain at the Portland Area Indian Health Service - Yakama Service Unit. The study will provide information on whether or not it is feasible to conduct a future fully-powered randomized controlled trial.

Primary Outcome

Successful recruitment is defined by the randomization of 30 study participants

Interventions

  • BEHAVIORAL Braided Skills for Managing Pain

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-06-15
Est. Completion 2028-11-30
Phase NA
University of California, San Diego

775 total trials

What NCT07524751 shows while recruiting

NCT07524751 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Braided Skills for Managing Pain is the first listed.

NCT07524751 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07524751 about?

NCT07524751 is a clinical study titled "Culturally Adapted Pain Management for Indigenous Peoples". The proposed study involves a randomized feasibility pilot trial of a culturally adapted psychological intervention for chronic pain for American Indian/Alaska Native (AI/AN) individuals receiving care for pain at the Portland Area Indian Health Service - Yakama Service Unit. The study will provide ...

What is the current status of trial NCT07524751?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-06-15. Estimated completion is 2028-11-30.

What interventions are being tested in trial NCT07524751?

The interventions under investigation include: Braided Skills for Managing Pain (BEHAVIORAL).

Who is sponsoring clinical trial NCT07524751?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07524751's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07524751, the US trial registry maintained by the National Library of Medicine. NCT07524751 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.